Royal Bank of Canada’s Oyster Point Pharma, Inc. Common Stock OYST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-2,997
| Closed | -$34K | – | 7266 |
|
|
2022
Q4 | $34K | Sell |
2,997
-82
| -3% | -$930 | ﹤0.01% | 5625 |
|
|
2022
Q3 | $16K | Buy |
3,079
+82
| +3% | +$426 | ﹤0.01% | 5755 |
|
|
2022
Q2 | $12K | Sell |
2,997
-682
| -19% | -$2.73K | ﹤0.01% | 5870 |
|
|
2022
Q1 | $42K | Sell |
3,679
-1,553
| -30% | -$17.7K | ﹤0.01% | 5724 |
|
|
2021
Q4 | $95K | Buy |
5,232
+581
| +12% | +$10.6K | ﹤0.01% | 5461 |
|
|
2021
Q3 | $55K | Buy |
4,651
+2,882
| +163% | +$34.1K | ﹤0.01% | 5592 |
|
|
2021
Q2 | $31K | Buy |
1,769
+327
| +23% | +$5.73K | ﹤0.01% | 5833 |
|
|
2021
Q1 | $27K | Buy |
1,442
+288
| +25% | +$5.39K | ﹤0.01% | 5770 |
|
|
2020
Q4 | $22K | Buy |
1,154
+142
| +14% | +$2.71K | ﹤0.01% | 5475 |
|
|
2020
Q3 | $21K | Buy |
1,012
+95
| +10% | +$1.97K | ﹤0.01% | 5200 |
|
|
2020
Q2 | $26K | Buy |
917
+886
| +2,858% | +$25.1K | ﹤0.01% | 5012 |
|
|
2020
Q1 | $1K | Sell |
31
-614
| -95% | -$19.8K | ﹤0.01% | 6042 |
|
|
2019
Q4 | $16K | Buy |
+645
| New | +$16K | ﹤0.01% | 5367 |
|